Innovis Medical

Facebook
Twitter
LinkedIn

Trauma disrupts every person’s blood clotting ability to stop bleeding and remains the second leading cause of preventable death in industrialized countries. With no effective medical device to provide physicians with full blood clotting data at the site of injury, medics resort to blind dosing that carries significant risk of internal blood clotting or having no effect altogether. While deployed, injured soldiers may not receive proper treatment for up to 24 hours. In the civilian sector, patient treatment may be delayed up to 3 hours before the data can be obtained at a hospital. At Innovis Medical, the team provides health care practitioners with the tools they need to diagnose clotting dysfunction at the point-of-care with a solid-state, disposable sensor capable of operating in mobile situations.

More Winners

Ricult (MIT)

70% of the world’s poor are smallholder farmers, and they produce 80% of the global food. However, these farmers are poor and food insecure. By

Read More »

Point of Care Device (UC Berkeley)

We are developing a novel, easy-to-use, patent-pending, point-of-care platform for multiplexed, digital disease detection. We have applied digital Integrated Circuit (IC) technology, the same technology

Read More »

Padhne.De (UC Berkeley)

While many developing countries have come a long way in increasing literacy rates, certain populations, like children in rural India, are still struggling with low

Read More »

© 2021 Blum Center for Developing Economies

Design by Joseph Kim